Randomised trials, human nature, and reporting guidelines

Lancet

Volumn 348, Issue 9027, 1996, Pages 596-598

  Schulz, Kenneth F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY;

EID: 0030608236     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)01201-9     Document Type: Note

References (26)

1. 1 CONSORT Group. Improving the quality of reporting of randomised controlled trials: the CONSORT statement. JAMA 1996; 276: 637-39.
2. 2 The Standards of Reporting Trials Group. A proposal for structured reporting of randomised controlled trials. JAMA 1994; 272: 1926-31.
3. 3 Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Ann Intern Med 1994; 121: 894-95.
4. 4 Grant JM. Randomised trials and the British Journal of Obstetrics and Gynaecology: minimum requirements for publication. Br J Obstet Gynaecol 1995; 102: 849-50.
5. 5 Rennie D. Reporting randomised controlled trials: an experiment and a call for responses from readers. JAMA 1995; 273: 1054-55.
6. 6 Altman DG, Doré CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990; 335: 149-53.
7. 7 Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomisation from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994; 272: 125-28.
8. 8 Mosteller F, Gilbert JP, McPeek B. Reporting standards and research strategies for controlled trials: agenda for the editor. Controlled Clin Trials 1980; 1: 37-58.
9. 9 DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med 1982; 306: 1332-37.
10. 10 Tyson JE, Furzan JA, Reisch JS, Mize SG. An evaluation of the quality of therapeutic studies in perinatal medicine. J Pediatr 1983; 102: 10-13.
11. 11 Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996; 347: 363-66.
12. 12 Williams DH, Davis CE. Reporting of assignment methods in clinical trials. Controlled Clin Trials 1994; 15: 294-98.
13. 13 Sonis J, Joines J. The quality of clinical trials published in The Journal of Family Practice J Fam Pract 1994; 39: 225-35.
14. 14 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
15. 15 Schulz KF. Subverting randomisation in controlled trials. JAMA 1995; 274: 1456-58.
16. 16 Schulz KF. Unbiased research and the human spirit: the challenges of randomised controlled trials. Can Med Assoc J 1995; 153: 783-86.
17. 17 Pocock SJ. Statistical aspects of clinical trial design. Statistician 1982; 31: 1-18.
18. 18 Various. Properties of randomisation in clinical trials. Controlled Clin Trials 1988; 9: 287-382.
19. 19 Carleton RA, Sander CA, Burack WR. Heparin administration after acute myocardial infarction. N Engl J Med 1960; 263: 1002-04.
20. 20 Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline I: control of bias and comparison with large cooperative trials. Stat Med 1987; 6: 315-25.
21. 21 Chalmers I, Hetherinton J, Elbourne D, Keirse MJNC, Enkin M. Materials and methods used in synthesising evidence to evaluate the effects of care during pregnancy and childbirth. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and child birth: volume I. Pregnancy. Oxford: Oxford University Press, 1989: 39-65.
22. 22 Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ 1996; 312: 742-44.
23. 23 Schulz KF, Chalmers I, Altman DG, Grimes DA, Doré CJ. The methodologic quality of randomisation as assessed from reports of trials in specialist and general medical journals. Online J Curr Clin Trials 1995 (doc no 197).
24. 24 Gøtzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Controlled Clin Trials 1989; 10: 31-56.
25. 25 Gøtzsche PC. Multiple publication of reports of drug trials. Eur J Clin Pharmacol 1989; 36: 429-32.
26. 26 Liberati A, Himel HN, Chalmers TC. A quality assessment of randomised control trials of primary treatment of breast cancer. J Clin Oncol 1986; 4: 942-51.